期刊文献+

基于磁分选技术和间接免疫荧光技术的肺癌A549细胞的分离检测 被引量:1

Isolation and detection of A549 lung cancer cells based on magnetic separation and indirect immunofluorescence technologies
下载PDF
导出
摘要 采用磁分选技术及间接免疫荧光技术分离检测肺癌循环肿瘤细胞(CTCs).将表皮生长因子受体(EGFR)抗体连接到四氧化三铁(Fe3O4)磁珠表面构建免疫磁珠(MNPs-Anti-EGFR),通过EGFR抗体和肺癌A549细胞的表面抗原的特异性结合,将免疫磁珠与肺癌细胞结合.通过磁场作用,使肺癌细胞在磁场的作用下从混合细胞中分离富集.分离出的细胞利用间接荧光技术在其细胞表面连接结合PE荧光团的特异性抗体,并用4',6-二脒基-2-苯基吲哚(DAPI)对细胞核染色以定位细胞位置.通过倒置荧光显微镜的观察,从而实现对肿瘤细胞的定量计数检测.实验结果显示该方法对肺癌A549细胞具有较好的检测灵敏度和检测下限,检测下限可达3 cells/m L. This article reports the development of a combining immunomagnetic separation technology with indirect immunofluores-cence technology for separating and determining of the carcinoma A549 cells. Magnetic beads weresynthesized by chemical precipita-tion. Immunomagneticbeads were constructed by grafted EGFR to the surface of Fe304 nanoparticles coated by lipid. The carcinoma A549 cells could specifically bind with the EGFR antibody on the immunomagnetic surface. The carcinoma A549 cells could be isolatedand enriched from the mixed cellsunder the action of in the magnetic field. The separated cells could connect with the specif-ic antibody contained PE fluorophore and the location of cellnucleus can be confirmed by DAPI to stain the cell nucleus. The carci-noma A549 cells could be quantitatively detectedbyobserving inversion fluorescence microscope. Al l those results indicate that the method of combining Immunomagnetic separation technology and indirect immunofluorescence technology have a good specificity and high sensitivity for isolationand detection of the carcinoma A549 cells, thedetection l imit is three cells per mi l l i l iter.
出处 《上海师范大学学报(自然科学版)》 2017年第4期489-498,共10页 Journal of Shanghai Normal University(Natural Sciences)
基金 国家自然科学基金面上项目(21373138) 上海教委创新计划项目(15ZZ070)
关键词 循环肿瘤细胞 磁分选技术 免疫荧光技术 肺癌A549细胞 CTCs immunomagneticseparationtechnology immunofluorescencetechnology carcinoma A549 cells
  • 相关文献

参考文献3

二级参考文献35

  • 1何成全,詹乾钢,单水阳,胡伯年,叶平江,冯刚,许焕建,付文安.胃癌患者外周血中CK19,CK20表达的临床研究[J].中国肿瘤临床,2005,32(7):401-403. 被引量:10
  • 2蔡清清,黄慧强,林天歆,姜文奇.乳腺癌患者外周血中循环癌细胞的检测及其临床意义[J].癌症,2005,24(7):837-841. 被引量:18
  • 3赵庆荣.糖链抗原CA19-9 RIA诊断消化道癌临床意义[J].中华核医学杂志,1987,7(2):75-75.
  • 4Paterlini-Brechot P,Benali NL.Circulating tumor cells (CTC) detection: clinical impact and future directions.Cancer Lett 2007; 253: 180-204.
  • 5Naoe M,Ogawa Y,Morita J,Omori K,Takeshita K,Shichijyo T,Okumura T,Igarashi A,Yanaihara A,Iwamoto S,Fukagai T,Miyazaki A,Yoshida H.Detection of circulating urothelial cancer cells in the blood using the CellSearch System.Cancer 2007; 109: 1439-1445.
  • 6Racila E,Euhus D,Weiss AJ,Rao C,McConnell J,Terstappen LW,Uhr JW.Detection and characterization of carcinoma cells in the blood.Proc Natl Acad Sci U S A 1998; 95: 4589-4594.
  • 7Cristofanilli M,Budd GT,Ellis MJ,Stopeck A,Matera J,Miller MC,Reuben JM,Doyle GV,Allard WJ,Terstappen LW,Hayes DF.Circulating tumor cells,disease progression,and survival in metastatic breast cancer.N Engl J Med 2004; 351: 781-791.
  • 8Cristofanilli M,Hayes DF,Budd GT,Ellis MJ,Stopeck A,Reuben JM,Doyle GV,Matera J,Allard WJ,Miller MC,Fritsche HA,Hortobagyi GN,Terstappen LW.Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.J Clin Oncol 2005; 23: 1420-1430.
  • 9Dawood S,Broglio K,Valero V,Reuben J,Handy B,Islam R,Jackson S,Hortobagyi GN,Fritsche H,Cristofanilli M.Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer 2008; 113: 2422-2430.
  • 10Budd GT,Cristofanilli M,Ellis MJ,Stopeck A,Borden E,Miller MC,Matera J,Repollet M,Doyle GV,Terstappen LW,Hayes DF.Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.Clin Cancer Res 2006; 12: 6403-6409.

共引文献33

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部